SLC25A5 and breast carcinoma: SSBP1, TXNRD1, SLC25A5, DDOST, SEH1L, and MCM2 had a significant effect in at least 50% of breast cancer cell lines in the CRISPR-Cas9 and/or RNAi screening data.